PDCD1 and cancer: Studies have suggested three potential contributions made by PD-1 signaling in NK cells during PD-1 blockade therapy: (1) HLA-I is generally not expressed in human cancer cells, resulting in no interaction between HLA-I and CD8 T cells83 84; however, PD-1-based immunotherapy is effective in these tumors.